Nizatidine Alternatives Compared
| Nizatidine | Omeprazole | Pantoprazole |
|
|---|
| Nizatidine | Omeprazole | Pantoprazole |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription and OTC
Prescribed for Erosive Esophagitis, GERD, Indigestion, Duodenal Ulcer, Duodenal Ulcer Prophylaxis, Stomach Ulcer. Nizatidine may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Omeprazole decreases stomach acid production which promotes the healing of gastric and duodenal ulcers and other inflamed areas of gastrointestinal tissue. The risk of interactions with omeprazole... View more |
Prescription only
Pantoprazole is a proton pump inhibitor that decreases acid secretion in the stomach and may be given to relieve the symptoms of heartburn or to allow inflamed tissue in the gastrointestinal tract to... View more |
Related suggestions Stomach Ulcer
Erosive Esophagitis
Duodenal Ulcer
|
|||||||||||||||||||||||
| More about Nizatidine | More about Omeprazole | More about Pantoprazole | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Nizatidine has an average rating of 9.2 out of 10 from a total of 13 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 0% reported a negative effect. |
Omeprazole has an average rating of 4.7 out of 10 from a total of 498 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 51% reported a negative effect. |
Pantoprazole has an average rating of 5.0 out of 10 from a total of 430 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 47% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Nizatidine side effects |
View all Omeprazole side effects |
View all Pantoprazole side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Nizatidine prices |
View all Omeprazole prices |
View all Pantoprazole prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Axid AR | Omesec, Prilosec, Prilosec OTC | Protonix, Protonix IV | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
2 hours |
1.5 hours |
1 hour |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 97 drugs are known to interact with Nizatidine:
|
A total of 240 drugs are known to interact with Omeprazole:
|
A total of 181 drugs are known to interact with Pantoprazole:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 12, 1988 |
June 20, 2003 |
February 02, 2000 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.